These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 28945556)

  • 1. [Hepatitis C: the serial killer pictured more than 25 years after his indictment].
    Piver E; Bull A; Roingeard P; Meunier JC
    Med Sci (Paris); 2017; 33(8-9):720-723. PubMed ID: 28945556
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis C virus: from discovery to eradication in 40 years?
    Pawlotsky JM
    Clin Microbiol Infect; 2011 Feb; 17(2):105-6. PubMed ID: 21091971
    [No Abstract]   [Full Text] [Related]  

  • 3. Probable visualization of the elusive hepatitis C virus.
    Alter HJ; Shih JW
    Hepatology; 1993 Jun; 17(6):1164-6. PubMed ID: 8390396
    [No Abstract]   [Full Text] [Related]  

  • 4. The unsung heroes of the Nobel-winning hepatitis C discovery.
    Ledford H
    Nature; 2020 Oct; 586(7830):485. PubMed ID: 33082542
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatitis C virus: detection of intracellular virus particles by electron microscopy.
    Shimizu YK; Feinstone SM; Kohara M; Purcell RH; Yoshikura H
    Hepatology; 1996 Feb; 23(2):205-9. PubMed ID: 8591842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Discovery of Hepatitis C - The 2020 Nobel Prize in Physiology or Medicine.
    Hoofnagle JH; Feinstone SM
    N Engl J Med; 2020 Dec; 383(24):2297-2299. PubMed ID: 33283991
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute hepatitis C virus infection: a dynamic-and challenging-concept.
    Irving WL; Brown RJ
    J Infect Dis; 2010 Dec; 202(12):1765-7. PubMed ID: 21067368
    [No Abstract]   [Full Text] [Related]  

  • 8. Innate and adaptive immunity shape circulating HCV strains.
    Gaudieri S; Lucas M
    Nat Genet; 2017 Apr; 49(5):657-658. PubMed ID: 28442794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PLA2R related primary membranous nephropathy in a hepatitis C positive patient.
    Ramachandran R; Yadav AK; Kumar V; Varma A; Taneja S; Nada R; Gupta KL; Jha V
    Nephrology (Carlton); 2018 Mar; 23(3):288. PubMed ID: 29460999
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatitis C: virus, host, disease.
    Ippolito G; Craxi A
    Cell Death Differ; 2003 Jan; 10 Suppl 1():S1-2. PubMed ID: 12655335
    [No Abstract]   [Full Text] [Related]  

  • 11. Host genetics in immune-mediated hepatitis C virus clearance.
    Schmidt J; Thimme R; Neumann-Haefelin C
    Biomark Med; 2011 Apr; 5(2):155-69. PubMed ID: 21473719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemophilia and cancer: a personal perspective.
    Franchini M
    Blood Transfus; 2013 Jan; 11(1):26-31. PubMed ID: 22790273
    [No Abstract]   [Full Text] [Related]  

  • 13. HCV and interferon: viral strategies for evading innate defence mechanisms in the virus-host battle.
    Capobianchi MR; Abbate I; Cappiello G; Solmone M
    Cell Death Differ; 2003 Jan; 10 Suppl 1():S22-4. PubMed ID: 12655342
    [No Abstract]   [Full Text] [Related]  

  • 14. Virologists who discovered hepatitis C win medicine Nobel.
    Callaway E; Ledford H
    Nature; 2020 Oct; 586(7829):348. PubMed ID: 33020621
    [No Abstract]   [Full Text] [Related]  

  • 15. Claudin-6 and Occludin Natural Variants Found in a Patient Highly Exposed but Not Infected with Hepatitis C Virus (HCV) Do Not Confer HCV Resistance In Vitro.
    Fénéant L; Ghosn J; Fouquet B; Helle F; Belouzard S; Vausselin T; Séron K; Delfraissy JF; Dubuisson J; Misrahi M; Cocquerel L
    PLoS One; 2015; 10(11):e0142539. PubMed ID: 26561856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies against hepatitis C virus-like particles and viral clearance in acute and chronic hepatitis C.
    Baumert TF; Wellnitz S; Aono S; Satoi J; Herion D; Tilman Gerlach J; Pape GR; Lau JY; Hoofnagle JH; Blum HE; Liang TJ
    Hepatology; 2000 Sep; 32(3):610-7. PubMed ID: 10960457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lasker Foundation announces award winners for 2016.
    Mohammadi D
    Lancet; 2016 Sep; 388(10050):1144-5. PubMed ID: 27637673
    [No Abstract]   [Full Text] [Related]  

  • 18. Failure of innate and adaptive immune responses in controlling hepatitis C virus infection.
    Thimme R; Binder M; Bartenschlager R
    FEMS Microbiol Rev; 2012 May; 36(3):663-83. PubMed ID: 22142141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ultrastructural features of the HCV particle and HCV-like particles].
    Watanabe S; Kaito M; Ishida S; Naoki F; Kohara M
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):10-9. PubMed ID: 15359756
    [No Abstract]   [Full Text] [Related]  

  • 20. Evasion of intracellular host defence by hepatitis C virus.
    Gale M; Foy EM
    Nature; 2005 Aug; 436(7053):939-45. PubMed ID: 16107833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.